Evidence map›Paper›PMID 29658984›Full record

ArticleActa anaesthesiologica Scandinavica2018

The SSAI fully supports the suspension of hydroxyethyl-starch solutions commissioned by the European Medicines Agency.

J H Laake, T I Tønnessen, M S Chew, M Lipcsey, H Hjelmqvist, E Wilkman, V Pettilä, J Hoffmann-Petersen, M H Møller, Board of the Scandinavian Society of Anaesthesiology Intensive Care Medicine (SSAI)

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta anaesthesiologica Scandinavica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Hydroxyethyl starch: the Paradigm of Eminence-Based Versus Evidence-Based Medicine-1.Turkish journal of anaesthesiology and reanimation · 2018
    Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

J H LaakeDepartment of Anaesthesiology, Division of Critical Care and Emergencies, Oslo University Hospital, Oslo, Norway.
T I TønnessenDepartment of Anaesthesiology, Division of Critical Care and Emergencies, Oslo University Hospital, Oslo, Norway.
M S ChewDepartment of Anaesthesia and Intensive Care, Medical and Health Sciences, Linköping University, Linköping, Sweden.
M LipcseyHedenstierna laboratory, Department of Surgical Sciences, Anaesthesiology and Intensive Care, CIRRUS, Uppsala University Hospital, Uppsala, Sweden.ORCID 0000-0002-1976-4129
H HjelmqvistSchool of Medical Sciences, Department of Anaesthesia and Intensive Care, Örebro University and University Hospital, Örebro, Sweden.
E WilkmanDepartment of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
V PettiläDepartment of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0002-3921-4423
J Hoffmann-PetersenDepartment of Anaesthesiology and Intensive Care, Odense University Hospital, Odense, Denmark.
M H MøllerDepartment of Intensive Care, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0002-6378-9673
Board of the Scandinavian Society of Anaesthesiology Intensive Care Medicine (SSAI)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnesthesiologyCritical CareHumansHydroxyethyl Starch DerivativesPlasma SubstitutesSocieties, MedicalSolutionsHydroxyethyl Starch DerivativesPlasma SubstitutesSolutions

Identifiers

PMID29658984
PMCPMC6690069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.